Estimated Cancer Prevalence by Cancer Site and Gender, New York State Excl New York City, 2020

Source: New York State Cancer Registry

Site of Cancer Diagnosed in Last 5 Years Ever Diagnosed
Males and Females Males Females Males and Females Males Females
All Invasive Malignant Tumors 252,100 125,200 126,900 712,200 331,800 380,400
Oral cavity and pharynx 6,600 4,600 2,000 16,000 10,600 5,400
Esophagus 1,400 1,100 300 2,600 2,000 600
Stomach 2,800 1,600 1,200 5,800 3,300 2,500
Colorectal 18,600 9,600 9,000 56,900 28,000 28,900
Liver / intrahepatic bile duct 2,100 1,500 600 3,500 2,400 1,000
Pancreas 3,200 1,700 1,600 4,800 2,400 2,400
Larynx 1,700 1,300 400 4,600 3,600 1,000
Lung and bronchus 20,800 8,900 11,900 34,400 14,400 20,100
Melanoma of the skin 14,300 8,100 6,200 42,600 22,200 20,400
Female breast     45,900     156,200
Cervix uteri     1,500     9,000
Corpus uterus and NOS     10,600     36,300
Ovary     2,900     10,200
Prostate   45,100     143,100  
Testis   1,700     10,700  
Urinary bladder (incl. in situ) 14,600 11,000 3,600 40,100 29,200 10,800
Kidney and renal pelvis 10,500 6,800 3,700 28,300 17,600 10,700
Brain and other central nervous system 1,900 1,100 900 7,600 3,900 3,600
Thyroid 10,600 2,900 7,700 40,500 9,700 30,800
Hodgkin lymphoma 1,700 900 800 9,800 5,000 4,800
Non-Hodgkin lymphomas 11,900 6,300 5,600 33,900 17,800 16,200
Myeloma 4,100 2,300 1,800 7,500 4,100 3,300
Leukemias 8,300 4,900 3,400 23,200 13,200 9,900

Notes

  • Estimated number of residents alive as of January 1, 2020, diagnosed with cancer within the last 5 years or anytime in the past, respectively.
  • Numbers are rounded to the nearest 100.
  • Refer to https://www.naaccr.org/wp-content/uploads/2020/01/CINA12-16.v5.sec1_.pdf for a detailed description of prevalence methodology.